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At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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SATURDAY, DECEMBER 29, 2007

Stem cells: the dawn of a new era for Huntington’s
disease research
The campaign for stem-cell research on Huntington’s disease took an
important step forward on December 12.
The 29 members of the governing board of California’s $3 billion stem-cell
institute heard from two leading HD researchers about the large potential
of stem-cell research in developing treatments for HD. The presentations
took place at the board’s monthly meeting, held at the University of
California, Los Angeles. These influential leaders from academia, the biotechnology industry, and patient advocate groups will decide in the coming
months whether a proposed California HD “disease team” will receive a
$50,000 planning grant and potentially millions of dollars for an
intensive, statewide effort to attack HD using stem cells.
A historic moment
For nearly an hour the Independent Citizens’ Oversight Committee (ICOC)
of the California Institute for Regenerative Medicine (CIRM) watched a
detailed presentation by Dr. Robert Pacifici, the chief scientific officer of
the California-based Cure Huntington’s Disease Initiative, Inc. (CHDI), Dr.
Hans Keirstead, a stem-cell dynamo at the University of California, Irvine,
and HD activist Frances Saldaña of Orange County and her daughter
Margie Hayes, one of three siblings who developed juvenile HD and the
mother of two at-risk children.

► March (3)
► February (1)
► 2006 (4)
► 2005 (17)

About Me
GENE VERITAS

View my complete profile

Working with my fellow activists in the San Diego chapter of the
Huntington’s Disease Society of America (HDSA), the Orange County
affiliate, and the Los Angeles chapter, I spearheaded the organization of
the CIRM’s “Spotlight on Huntington’s Disease.” Like previous CIRM
spotlights on other diseases, this event was open to the public. I joined HD
researchers, activists, and families from throughout southern California to
provide support and witness this historic moment in Huntington’s disease
advocacy.
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I was especially heartened to see HD take center stage in California and
hear the scientists’ optimism about stem cells for HD research. Many of us
in the HD community have felt intuitively that stem cells are crucial in the
search for a cure and should receive emphasis immediately. At the CIRM
meeting I had the strong sensation of being fast-forwarded into a future
where HD will no longer threaten the lives of people like Margie, who, her
speech impeded and her body dancing uncontrollably, moved ICOC chair
Robert Klein and the rest of the audience with her sad story of testing
positive for HD, suffering discrimination, and becoming incapacitated.
CHDI efforts
Dr. Pacifici, whose non-profit CHDI has stepped in where the big drug
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companies have failed to venture, stressed the importance of stem cells in
recreating the actual human version of the disease in a Petri dish. CHDI,
he explained, has set up some twenty parallel programs aimed at finding
treatments.
“Without exception there isn’t a program in our portfolio that wouldn’t
benefit dramatically from having a stem-cell-derived cell population in its
flow scheme,” he stated. HD stem cells would enable researchers to
understand such puzzles as the differing ages of onset in those individuals
with identical genetic defects (the so-called CAG repeats of Huntington’s
disease) and whether brain cells are dying as a result of “murder or
suicide.”
Significantly, stem cells would speed up the process of screening for drugs,
Pacifici said.
New hope
Pacifici then offered the kind of hope that I could only dream of as my own
mother withered away and ultimately died because of Huntington’s nearly
two years ago – a hope that I can now cling to as I approach my own
inevitable symptoms. The same cocktail of compounds used to turn stem
cells into brain cells in a Petri dish, Pacifici stated, could be used as drugs
to repopulate damaged areas of the brain with new cells. “It may be that we
can change our aspiration from preventing or slowing Huntington’s, to
actually reversing Huntington’s disease, if the promise of regenerative
medicines and cell-based therapies comes to fruition,” he said.
Dr. Keirstead underscored the urgency of using stem cells in HD research
and detailed how the hope can become reality.
“I was an absolute convert to HD,” said Keirstead of the request by UC
Irvine colleague Dr. Leslie Thompson that he ply his internationally
recognized stem-cell expertise in the area of Huntington’s. “Huntington’s
disease is truly, in my opinion, one of the few diseases that’s applicable in
the short-term” to two key stem-cell research strategies – using cells to
understand how the disease works and to actually treat people. HD’s
character as a disease with a single, discovered genetic cause and its
impact on specific areas of the brain make it one of those unique
candidates for stem-cell research, he explained.
Little scientific attention
Despite this enormous potential, HD stem-cell research has received little
attention from the scientific community.
“It absolutely amazes me that there is not a handful – not one – human
embryonic stem-cell line of HD…. Not a one in the entire world,” Keirstead
stated, referring to the lack of scholarly articles on stem cells derived from
human HD embryos. “That’s just remarkable. With the technologies of
deriving embryonic stem cells from blastocysts [the human before it
becomes an embryo], with the adoption of prenatal genetic diagnosis by
many HD-bearing couples, it amazes me that we don’t yet have a stem-cell
line or two or three or four or thirty or three hundred that bear this
mutation, a mutation of a gene that we absolutely know of and that we
have access to…. Yet we know precisely how to obtain those things. We
know very routinely how to make them…. This is going to be one of the
major, major tools.”
Keirstead and UCI are wasting no time in taking the lead. “We are deriving
new lines at UCI,” Keirstead explained. “I have recently established
relationships with fertility clinics. I now have access to over 10,000
blastocysts a month. That’s phenomenal…. We are already receiving phone
calls from people with Huntington’s disease that have [gone to] fertility
clinics that have HD-positive blastocysts that they would like to channel
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our way. I have about fourteen such individuals so far with the three
fertility clinics that I am working with.”
Thinking long-term
Keirstead is a strategic thinker who sees the long-term implications of his
work.
“You can’t walk into the FDA – two guys and a rat – and say, ‘Let me try
this in humans,’” he said. Keirstead transforms stem cells into other cells
in a manner compliant with the standards of the Food and Drug
Administration and in quantities large enough to make their use
commercially viable for large biotech companies. He deals in not just “a
few cells in a dish,” but in the billions. Only in this way, he explained, will a
company invest the many millions of dollars necessary to getting the stemcell process to treatments. Keirstead’s work includes pushing stem cells to
become neurons for the striatum, the area of the brain devastated by
Huntington’s disease.
“I don’t think we should lose sight of the power of this. If we can actually
make high-purity populations of striatal interneurons, what’s going to
happen to this field is precisely what’s going to happen to the spinal cord
field, which is: a commercial entity will come in and value-add, that more
researchers will take those cells… and begin working on them in highpurity format. And we’re going to see a turning point. It’s the dawn of a
new era for HD.”
Increased advocacy role
I hope that the CIRM spotlight on HD was also a new dawn for HD
advocacy and Californians’ central role in it. In chairman Klein’s words,
“The Huntington’s organization’s patient advocacy is extraordinary. I have
tremendous respect for the passion, intensity, tenacity, and commitment
of the Huntington’s organization.” Klein had earlier noted that HDSA was
the only disease advocacy group to have done presentations in both the
CIRM “spotlight” format and in the public hearing of the ICOC board. The
previous presentation took place at the October 3 CIRM meeting in San
Diego, where HDSA-San Diego president and San Diego Chargers’ public
relations director Bill Johnston and his wife Ramona, who has HD,
appealed to the board to support HD research.
The December 12 spotlight came just weeks after CHDI announced
another stunning new project in HD research to take place in southern
California. On October 26 CHDI and Carlsbad-based Isis Pharmaceuticals,
Inc. revealed that they would collaborate in a multi-million-dollar effort to
develop a drug to target directly the huntingtin gene, the cause of
Huntington’s disease. I will write about this exciting development in a
future entry.
Posted by Gene Veritas at 2:52 PM

2 comments:
Anonymous said...
Hi- you write about there being no stem cell lines for HD. My
husband and I have persnally donated for science our
remaining embryos after PDG. I am wondering if you have any
recommendations on how I can follow up on this to understand
what happen to them and if we decide to do PGD again, where
should we go to donate?
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reneel72@comcast.net
10:03 AM, January 18, 2008

Angela_F said...
Oooh I'd be interested in doing that, we're going for PGD in the
next few months. Will send you an email to ask about that
though.
9:04 AM, April 23, 2008
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